Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel copper-catalyzed route offers high yields and mild conditions for synthesizing bioactive benzofuropyridine intermediates, ensuring supply chain stability.
Novel patent CN1884242A offers high-purity 9-fluorenylmethanol synthesis with enhanced safety and cost efficiency for global supply chains.
Novel Ir-catalyzed process for S-indoline-2-carboxylic acid offers high purity and yield. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Novel patent CN113493458B offers safer temozolomide production without methyl isocyanate ensuring high purity and supply chain stability for pharmaceutical intermediates.
Novel antibacterial intermediate synthesis via convergent route reduces heavy metal waste and improves scalability for API manufacturing significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking cost-effective production.
Patent CN115232151A reveals a novel silylation protection method for ceftriaxone sodium, offering higher purity and simplified manufacturing for reliable API suppliers.
Patent CN101307040B details a novel NBS derivatization method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel low-temperature route for budesonide-17-acetate intermediate. High purity, reduced impurities, scalable manufacturing for global pharmaceutical supply chains.
Patent CN101891743B details a promoter-assisted rhodium catalysis route for meropenem intermediates, offering reduced catalyst loading and telescoped processing for supply chain efficiency.
Patent CN101307040B details a novel NBS addition method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in API manufacturing and high purity.
Patent CN108358880A reveals ionic liquid catalysis for high-purity 4H-benzo[b]pyran compounds. Achieve cost reduction in pharmaceutical intermediates manufacturing with solvent-free technology.
Patent CN109761886B reveals a superior resolution method for Argatroban intermediates using D-(+)-dibenzoyltartaric acid, achieving 99.1% optical purity and enhanced manufacturing efficiency.
Patent CN107434802A details asymmetric oxidation for Esomeprazole sodium ensuring high purity and yield for reliable pharmaceutical intermediates supplier cost reduction.
Patent CN117069732B details a high-purity synthesis route for benzo[c]phenanthridine alkaloids, offering supply chain reliability and cost-effective manufacturing for global pharmaceutical partners.
Patent CN111960997B reveals a mild silver-catalyzed route for hydroxyalkyl quinolines, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Novel solid-phase synthesis reduces impurities and improves yield for Icatibant manufacturing ensuring supply chain stability and cost efficiency.
Patent CN1298711C reveals a novel route for antifungal intermediates, eliminating protection steps for significant cost reduction and supply chain reliability.
Patent CN104480181B reveals enzymatic D-7-ACA synthesis. High purity and yield offer supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel Rh(I) catalyzed method for chiral boranes. High ee, mild conditions. Cost-effective supply chain solution for pharma intermediates.
Discover the advanced synthesis of dihydropyrazole thiazole derivatives via patent CN103664926A. High-yield, scalable routes for oncology drug development and reliable supply.